Reported 2 days ago
Jim Cramer discussed Eli Lilly's recent developments, particularly its weight-loss and diabetes pill, which he believes could significantly impact the market. Although he mentioned the less critical nature of a memory loss treatment recently approved by Eli Lilly, Cramer emphasized the strong performance expectations for the weight-loss pill, projecting it could help users lose between 12 to 15 pounds. This positive outlook contributed to a notable increase in Eli Lilly's stock price.
Source: YAHOO